查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790346

美國細胞培養基和細胞株市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Cell Culture Media & Cell Lines Market Size, Share & Trends Analysis Report By Product (Traditional Cell Line, Classical Media), By Application (Biopharmaceutical Production, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

美國細胞培養基和細胞株市場規模預計將在 2024 年達到 19.7 億美元，到 2033 年將達到 43.6 億美元，2025 年至 2033 年的複合年成長率為 9.45%。

這一成長將受到生物製藥製造需求的不斷成長、再生醫學的進步以及研發活動投資的不斷增加的推動。此外，細胞培養技術在藥物發現和個人化醫療中的日益廣泛的應用預計將在預測期內推動市場擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國細胞培養基和細胞株市場變數和趨勢

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國細胞培養基與細胞株市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章：美國細胞培養基與細胞株市場（依產品、估價及趨勢分析）

  • 產品細分儀表板
  • 美國細胞培養基與細胞株市場產品波動分析
  • 2021-2033 年美國細胞培養基及細胞株市場規模及趨勢分析（依產品）
  • 常規細胞株
    • 市場規模與趨勢分析（按產品，2021-2033）
  • 常規培養基
    • 市場規模與趨勢分析（按產品，2021-2033）
  • 幹細胞和血液衍生細胞
    • 市場規模與趨勢分析（按產品，2021-2033）
  • 專用培養基產品
    • 市場規模與趨勢分析（按產品，2021-2033）

第5章：美國細胞培養基和細胞株市場的應用、預測與趨勢分析

  • 應用程式細分儀表板
  • 美國細胞培養基和細胞株市場使用變化分析
  • 美國細胞培養基及細胞株市場規模及應用趨勢分析（2021-2033）
  • 生物製藥製造
  • 診斷
  • 藥物篩檢與開發
  • 組織工程與再生醫學
  • 其他

第6章：美國細胞培養基和細胞株市場（依最終用途、估計和趨勢分析）

  • 最終用途細分儀表板
  • 美國細胞培養基和細胞株市場的最終用途差異分析
  • 美國細胞培養基及細胞株市場規模及趨勢分析（依最終用途）（2021-2033）
  • 大型生物製藥公司
  • 中小型生技公司
  • 合約研究與製造組織（CRO/CMO）
  • 研究和學術機構
  • 醫院和診斷實驗室
  • 其他

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Lonza
    • STEMCELL Technologies
    • PromoCell GmbH
    • ATCC
    • AllCells
Product Code: GVR-4-68040-680-4

Market Size & Trends:

The U.S. cell culture media & cell lines market size was valued at USD 1.97 billion in 2024 and is anticipated to reach USD 4.36 billion by 2033, growing at a CAGR of 9.45% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceutical production, advancements in regenerative medicine, and rising investments in research and development activities. Moreover, the expanding application of cell culture technologies in drug discovery and personalized medicine will fuel market expansion further over the forecast period.

U.S. Cell Culture Media And Cell Lines Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For

this study, Grand View Research has segmented the U.S. cell culture media & cell lines market report on the basis of product, application, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Traditional Cell Lines
  • Classical Media
  • Stem Cells & Blood-derived Cells
  • Specialty Media Products
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Production
  • Diagnostics
  • Drug Screening and Development
  • Tissue Engineering and Regenerative Medicine
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Biopharmaceutical Companies
  • Small and Mid-sized Biotechnology Companies
  • Contract Research and Manufacturing Organizations (CROs/CMOs)
  • Research and Academic Institutes
  • Hospitals and Diagnostic Laboratories
  • Other End Uses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Cell Culture Media & Cell Lines Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in Regenerative Medicine
      • 3.2.1.2. Advancements in Technology and Data Analytics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Specialized Media and Cell Lines
      • 3.2.2.2. Stringent Regulatory and Quality Requirements
  • 3.3. U.S. Cell Culture Media & Cell Lines Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Media & Cell Lines Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Cell Culture Media & Cell Lines Market Product Movement Analysis
  • 4.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Traditional Cell Lines
    • 4.4.1. Traditional Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.5. Classical Media
    • 4.5.1. Classical Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.6. Stem Cells & Blood-derived Cells
    • 4.6.1. Stem Cells & Blood-derived Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.7. Specialty Media Products
    • 4.7.1. Specialty Media Products Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Media & Cell Lines Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Cell Culture Media & Cell Lines Market Application Movement Analysis
  • 5.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biopharmaceutical Production
    • 5.4.1. Biopharmaceutical Production market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Screening and Development
    • 5.6.1. Drug Screening and Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Tissue Engineering and Regenerative Medicine
    • 5.7.1. Tissue Engineering and Regenerative Medicine market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other Applications market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Media & Cell Lines Market: End use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. U.S. Cell Culture Media & Cell Lines Market End use Movement Analysis
  • 6.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 6.4. Large Biopharmaceutical Companies
    • 6.4.1. Large Biopharmaceutical Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Small and Mid-sized Biotechnology Companies
    • 6.5.1. Small and Mid-sized Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research and Manufacturing Organizations (CROs/CMOs)
    • 6.6.1. Contract Research and Manufacturing Organizations (CROs/CMOs) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Research and Academic Institutes
    • 6.7.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Hospitals and Diagnostic Laboratories
    • 6.8.1. Hospitals and Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. Other End Uses
    • 6.9.1. Other End Uses market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lonza
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. STEMCELL Technologies
      • 7.4.7.1. Company overview
      • 7.4.7.2. Product benchmarking
      • 7.4.7.3. Strategic initiatives
    • 7.4.8. PromoCell GmbH
      • 7.4.8.1. Company overview
      • 7.4.8.2. Product benchmarking
      • 7.4.8.3. Strategic initiatives
    • 7.4.9. ATCC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Product benchmarking
      • 7.4.9.3. Strategic initiatives
    • 7.4.10. AllCells.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Product benchmarking
      • 7.4.10.3. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. cell culture media & cell lines Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. cell culture media & cell lines Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 U.S. cell culture media & cell lines Market, By End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. cell culture media & cell lines market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. cell culture media & cell lines market: Product outlook key takeaways
  • Fig. 13 U.S. cell culture media & cell lines market: Product movement analysis
  • Fig. 14 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. classical media market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. stem cells & blood-derived cells U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. specialty media products U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. cell culture media & cell lines market: Application outlook and key takeaways
  • Fig. 20 U.S. cell culture media & cell lines market: Application movement analysis
  • Fig. 21 U.S. biopharmaceutical production market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. drug screening and development market, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. tissue engineering and regenerative medicine market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. other market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. cell culture media & cell lines market: End use outlook and key takeaways
  • Fig. 27 U.S. cell culture media & cell lines market: End use movement analysis
  • Fig. 28 U.S. large biopharmaceutical companies market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. small and mid-sized biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. contract research and manufacturing organizations (CROs/CMOs) market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. research and academic institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. hospital and diagnostic laboratories market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. other end use market, 2021 - 2033 (USD Million)